BRUSSELS, BELGIUM / RankWire.AI / – The European Commission has broadened its Ebola response efforts through a €2.1 million investment in PCR testing for the Bundibugyo virus outbreak. This initiative involves the procurement of open-platform tests that laboratories can integrate with their current systems. The procurement process received support from the European Health and Digital Executive Agency. Delivery of the tests is expected to commence in August, as health teams tackle a significant outbreak centered in the Democratic Republic of the Congo and impacting surrounding regions.
The World Health Organization will facilitate the distribution of these tests via its Hub for Global Health Emergencies Logistics located in Dubai. WHO will oversee the distribution to various locations engaged in the Ebola response. PCR testing enables laboratories to verify infections and bolster surveillance around known cases. Results confirmed through this method are crucial for guiding patient management, isolation protocols, and contact tracing. The recent supply package enhances laboratory resources at a critical time when authorities are monitoring ongoing transmission in multiple provinces and health zones within the Democratic Republic of the Congo.
Previously, the European Commission allocated an additional €2.5 million for rapid molecular point-of-care tests and testing equipment. These tools are intended to support the Africa Centres for Disease Control and Prevention in their regional response efforts. Now, the two diagnostic agreements combined total €4.6 million. These investments form part of a broader European assistance package aimed at supporting countries affected by the Bundibugyo Ebola outbreak. This support encompasses medical supplies, preparedness initiatives, and public health resources designed to strengthen responses in affected and neighboring areas.
Testing capacity expands amid a significant outbreak
According to WHO data, the Democratic Republic of the Congo had reported 4,665 confirmed cases and 2,184 deaths by August 12. Infections had been detected across 54 health zones in six provinces, including Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, and Bas-Uélé. WHO characterized this as the largest Ebola outbreak recorded in the country. The agency also highlighted ongoing transmission within connected geographic clusters, which continues to place high demands on surveillance teams, laboratories, treatment centers, and local health services.
In its August update, WHO maintained a very high national risk assessment for the Democratic Republic of the Congo. It categorized the risk for neighboring countries as high and the risk elsewhere as low. Following a meeting of its International Health Regulations Emergency Committee on August 24, WHO issued updated temporary recommendations. These guidelines address surveillance, case detection, infection prevention, clinical care, and community engagement. They also include public health measures related to mobility and large gatherings during this ongoing response effort.
European health aid reaches €493 million
The European Commission announced the mobilization of €493 million for emergency response, vaccines, treatment, and health security efforts across the Great Lakes and Uganda regions. European health agencies have contributed to laboratory testing, surveillance, and preparedness initiatives. The European Centre for Disease Prevention and Control continues to assess the risk to Europe as very low. Ebola predominantly spreads through contact with infected bodily fluids, making rapid detection, safe clinical practices, and effective infection control measures essential to limiting its transmission.
The ongoing Bundibugyo virus outbreak is classified as a public health emergency of international concern under WHO’s international health framework. Currently, there are no approved vaccines or specific treatments targeting Bundibugyo virus disease. Consequently, health authorities rely on surveillance, rapid diagnostics, isolation, clinical management, infection control, and close monitoring of contacts. The newly supplied PCR tests will bolster testing capacity for these efforts. WHO, Africa CDC, and national health agencies continue to coordinate responses as countries strive to identify cases quickly and uphold public health measures in affected communities.